These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15930076)

  • 41. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity and metabolic syndrome in a psychiatric rehabilitation service.
    Tirupati S; Chua LE
    Aust N Z J Psychiatry; 2007 Jul; 41(7):606-10. PubMed ID: 17558623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of cardiovascular risk in an Italian psychiatric outpatient sample: A chart review of patients treated with second-generation antipsychotics.
    Severi E; Ferrara M; Tedeschini E; Vacca F; Mungai F; Amendolara R; Baccari F; Starace F
    Int J Ment Health Nurs; 2018 Jun; 27(3):1002-1008. PubMed ID: 29197134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Metabolic syndrome induced by antipsychotic drugs. The problem of obesity].
    Jufe GS
    Vertex; 2008; 19(82):338-47. PubMed ID: 19424516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypertensive waist: first step of the screening for metabolic syndrome.
    Nita C; Hancu N; Rusu A; Bala C; Roman G
    Metab Syndr Relat Disord; 2009 Apr; 7(2):105-10. PubMed ID: 19032044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk.
    Salazar MR; Carbajal HA; Espeche WG; Dulbecco CA; Aizpurúa M; Marillet AG; Echeverría RF; Reaven GM
    Diab Vasc Dis Res; 2011 Apr; 8(2):109-16. PubMed ID: 21562062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computer-based screening of veterans for metabolic syndrome.
    Keane J; Meier JL; Noth RH; Swislocki AL
    Metab Syndr Relat Disord; 2009 Dec; 7(6):557-61. PubMed ID: 19558266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Weight gain and metabolic syndrome among young patients on antipsychotic medication: what do we know and where do we go?
    Eapen V; John G
    Australas Psychiatry; 2011 Jun; 19(3):232-5. PubMed ID: 21682621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
    Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
    Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The metabolic syndrome and antipsychotics in children and adolescents].
    Dori N; Green T
    Harefuah; 2011 Oct; 150(10):791-6, 814, 813. PubMed ID: 22111125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
    Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
    Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.
    Vancampfort D; Vansteelandt K; Correll CU; Mitchell AJ; De Herdt A; Sienaert P; Probst M; De Hert M
    Am J Psychiatry; 2013 Mar; 170(3):265-74. PubMed ID: 23361837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of melatonin in reducing second-generation antipsychotic metabolic effects: A double blind controlled clinical trial.
    Agahi M; Akasheh N; Ahmadvand A; Akbari H; Izadpanah F
    Diabetes Metab Syndr; 2018; 12(1):9-15. PubMed ID: 28847468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?
    Van Schependom J; Yu W; Gielen J; Laton J; De Keyser J; De Hert M; Nagels G
    J Clin Psychiatry; 2015 Oct; 76(10):e1292-9. PubMed ID: 26528652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview].
    Scheepers-Hoeks AM; Wessels-Basten SJ; Scherders MJ; Bravenboer B; Loonen AJ; Kleppe RT; Grouls RJ
    Tijdschr Psychiatr; 2008; 50(10):645-54. PubMed ID: 18951343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic Side Effects in Patients Using Atypical Antipsychotic Medications During Hospitalization.
    Dikeç G; Arabaci LB; Uzunoglu GB; Mizrak SD
    J Psychosoc Nurs Ment Health Serv; 2018 Apr; 56(4):28-37. PubMed ID: 29328360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second-Generation Antipsychotic Utilization and Metabolic Parameter Monitoring in an Inpatient Pediatric Population: A Retrospective Analysis.
    Nolt VD; Kibler AV; Wilkening GL; Fabian TJ
    Paediatr Drugs; 2017 Apr; 19(2):139-146. PubMed ID: 28074349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between insulin resistance and C-reactive protein in a patient population treated with second generation antipsychotic medications.
    Kim SH; Reaven G; Lindley S
    Int Clin Psychopharmacol; 2011 Jan; 26(1):43-7. PubMed ID: 20861740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.